| 中文别名 |
替米沙坦;4-{[2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑-1-基]甲基}联苯基-2-羧酸;4'-[[2-丙基-4-甲基-6(1-甲基苯并咪唑-2-基)-苯并咪唑-1-基]甲基]-2-联苯羧酸;4′-[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑-1-基甲基]联苯基-2-羧酸;替米沙坦 4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1氢-苯并咪唑]-1'-基)甲基]-[1,1'-联苯]-2-羧酸;4'-[[1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-甲基]-[1,1'-联苯基]-2-羧酸,二甲基乙基酯;泰米沙坦;2-(2H-苯并三唑)-5-正己氧基苯酚;4'-[[1,4'-二甲基-2'-丙基(2,6'-联-1H-苯并咪唑)-1'-甲基]-[1,1'-联苯基]-2-羧酸叔丁酯;4-[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑基甲基]联苯基-2-羧酸;Telmisartan 替米沙坦;氘代丁醇;替米沙;替米沙坦 EP标准品;替米沙坦 USP标准品;替米沙坦 标准品;替米沙坦峰鉴别 EP标准品;替米沙坦及其杂质标准品;替米沙坦系统适应性 EP标准品;盐酸坦索罗辛-D4;4'-[[2-丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)-苯并咪唑-1-基]甲基]-2-联苯羧酸;4'-[[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑-1-基]甲基]联苯-2-羧酸;替米沙坦(对照品) |
| 英文别名 |
4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid;TU-199;TELMISARTAN;PRITOR;MICARDIS;BIBR 277;4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID;4'-[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID;3-methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl sulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene;4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid;4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid;替米沙坦;Kinzalmono;BIBR 277SE;Telmisattan;Targit;Telmisartan [INN];4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid;U5SYW473RQ;C33H30N4O2;2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]ph;s1738;s1738;TELMISARTAN (USP-RS);4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID;TELMISARTAN (USP-RS);KS-1215;4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID;TELMISARTAN [ORANGE BOOK];KS-1215;NSC 759811;TELMISARTAN [ORANGE BOOK];EN300-123532;NSC 759811;EN300-123532;4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid;4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid;SBI-0206733.P001;SBI-0206733.P001;144701-48-4;144701-48-4;TELMISARTAN [GREEN BOOK];TELMISARTAN [GREEN BOOK];AC-2013;AC-2013;TELMISARTAN (USP MONOGRAPH);TELMISARTAN (USP MONOGRAPH);BIBR-277 SE;BIBR-277 SE;NS00000398;NS00000398;ALBB-028954;ALBB-028954;BIBR-277SE;BIBR-277SE;BRD-K73999723-001-02-2;BRD-K73999723-001-02-2;DL-511;DL-511;TELMISARTAN COMPONENT OF TWYNSTA;TELMISARTAN COMPONENT OF TWYNSTA;Telsite;Telsite;4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid;4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid;HMS3393P16;HMS3393P16;Kinzal;Kinzal;Telmisartan Actavis;Telmisartan Actavis;TELMISARTAN [EP IMPURITY];TELMISARTAN [EP IMPURITY];SPECTRUM1505261;SPECTRUM1505261;AB07687;AB07687;NCGC00095150-01;NCGC00095150-01;Telmisartan, European Pharmacopoeia (EP) Reference Standard;Telmisartan, European Pharmacopoeia (EP) Reference Standard;TELMISARTAN [EP MONOGRAPH];TELMISARTAN [EP MONOGRAPH];TELMISARTAN [EMA EPAR];TELMISARTAN [EMA EPAR];HY-13955;HY-13955;4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid;4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid;Micardis (TN);Micardis (TN);Q733186;Q733186;Telmisartan, United States Pharmacopeia (USP) ... |
微信公众号
客服
N)CC(%3dO)O)
